170 related articles for article (PubMed ID: 20232404)
1. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
[TBL] [Abstract][Full Text] [Related]
2. Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography.
Xia Y; Kudo M; Minami Y; Hatanaka K; Ueshima K; Chung H; Hagiwara S; Inoue T; Ishikawa E; Kitai S; Takahashi S; Tatsumi C; Ueda T; Hayaishi S; Maekawa K
Oncology; 2008; 75 Suppl 1():99-105. PubMed ID: 19092278
[TBL] [Abstract][Full Text] [Related]
3. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.
Luo W; Numata K; Morimoto M; Oshima T; Ueda M; Okada M; Takebayashi S; Zhou X; Tanaka K
Eur J Radiol; 2010 Jul; 75(1):91-7. PubMed ID: 19361941
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT.
Ding H; Kudo M; Onda H; Suetomi Y; Minami Y; Chung H; Kawasaki T; Maekawa K
Radiology; 2001 Dec; 221(3):721-30. PubMed ID: 11719668
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
Kim YK; Kwak HS; Han YM; Kim CS
J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
[TBL] [Abstract][Full Text] [Related]
6. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
Eur Radiol; 2024 Jun; 34(6):3795-3812. PubMed ID: 37989916
[TBL] [Abstract][Full Text] [Related]
7. Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation.
Lim HS; Jeong YY; Kang HK; Kim JK; Park JG
AJR Am J Roentgenol; 2006 Oct; 187(4):W341-9. PubMed ID: 16985104
[TBL] [Abstract][Full Text] [Related]
8. Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.
Ban JY; Kang TW; Jeong WK; Lee MW; Park B; Song KD
PLoS One; 2024; 19(5):e0304352. PubMed ID: 38787832
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT.
Salvaggio G; Campisi A; Lo Greco V; Cannella I; Meloni MF; Caruso G
Abdom Imaging; 2010 Aug; 35(4):447-53. PubMed ID: 19562414
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.
Maruyama H; Takahashi M; Ishibashi H; Okugawa H; Okabe S; Yoshikawa M; Yokosuka O
Liver Int; 2009 May; 29(5):708-14. PubMed ID: 18803588
[TBL] [Abstract][Full Text] [Related]
11. Power Doppler sonography assessment of tumor recurrence after chemoembolization therapy for hepatocellular carcinoma.
Sumi S; Yamashita Y; Mitsuzaki K; Yamamoto H; Urata J; Nishiharu T; Takahashi M
AJR Am J Roentgenol; 1999 Jan; 172(1):67-71. PubMed ID: 9888742
[TBL] [Abstract][Full Text] [Related]
12. Perfluorobutane (Sonazoid) Contrast-enhanced ultrasound to diagnose hepatocellular carcinoma: A systematic review and meta-analysis.
Chen Y; Zhu W; Yi Y; Cao H; Chen F; Zhu Q
Med Ultrason; 2024 Jun; 26(2):187-196. PubMed ID: 38537180
[TBL] [Abstract][Full Text] [Related]
13. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.
Yu JS; Kim JH; Chung JJ; Kim KW
J Magn Reson Imaging; 2009 Jul; 30(1):153-60. PubMed ID: 19557734
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography.
Minami Y; Kudo M; Kawasaki T; Kitano M; Chung H; Maekawa K; Shiozaki H
AJR Am J Roentgenol; 2003 Mar; 180(3):703-8. PubMed ID: 12591679
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.
Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Zhou X; Tanaka K
Eur J Radiol; 2009 Dec; 72(3):425-31. PubMed ID: 18930616
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent.
Numata K; Fukuda H; Ohto M; Itou R; Nozaki A; Kondou M; Morimoto M; Karasawa E; Tanaka K
Eur J Radiol; 2010 Aug; 75(2):e67-75. PubMed ID: 20015603
[TBL] [Abstract][Full Text] [Related]
17. Improved detection of hepatic metastases with contrast-enhanced low mechanical-index pulse inversion ultrasonography during the liver-specific phase of sonazoid: observer performance study with JAFROC analysis.
Sugimoto K; Shiraishi J; Moriyasu F; Saito K; Doi K
Acad Radiol; 2009 Jul; 16(7):798-809. PubMed ID: 19394876
[TBL] [Abstract][Full Text] [Related]
18. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
[TBL] [Abstract][Full Text] [Related]
19. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: Evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen.
Kim YS; Rhim H; Lim HK; Park CK; Lee WJ; Do YS; Cho JW
J Comput Assist Tomogr; 2006; 30(4):578-82. PubMed ID: 16845287
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
Korenaga K; Korenaga M; Furukawa M; Yamasaki T; Sakaida I
J Gastroenterol; 2009; 44(7):733-41. PubMed ID: 19387532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
